Back to search

Article

Therapeutic potential of SOX9 dysruption in Combined Hepatocellular Carcinoma-Cholangiocarcinoma

2024-05-23

Abstract excerpt

<h4>ABSTRACT</h4> Combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA) represents a challenging subtype of primary liver cancer with limited treatment options and a poor prognosis. Recently, we and others have highlighted the context-dependent roles of the biliary-specific transcription factor SOX9 in the pathogenesis of liver cancers using various Cre applications in Sox9 (flox/flox) strains, to ach...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
090610c1-3f06-559b-a5e4-7b7c85fa510d
DOI
10.1101/2024.05.22.595319
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapeutic potential of SOX9 dysruption in Combined Hepatocellular Carcinoma-CholangiocarcinomaDOI 10.1101/2024.05.22.595319
Select a neighboring publication to make it the new centre.